Myriad Genetics to buy VC-backed Counsyl for $375 mln
Myriad Genetics has agreed to acquire South San Francisco-based Counsyl, a provider of DNA screening, for $375 million. Lazard is providing financial advice to Myriad Genetics on the deal with Mintz Levin Cohn Ferris Glovsky and Popeo PC acting as legal counsel. And, Piper Jaffray is providing financial advice to Counsyl while Cooley LLP is serving as legal counsel. Counsyl's backers include Goldman Sachs, Founders Fund, Pilot Growth Equity and Felicis Ventures.
29 May 2018•6 mins read
